Leslie W. Kreis serves as Executive at Lantern Pharma Inc., where they oversee executive responsibilities. Since joining the company, Leslie W. Kreis has executed 9 insider transactions totaling $186.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 7, 2024 involved receiving (via award) 8,500 shares valued at $0.
Leslie W. Kreis currently holds 14,500 shares of Lantern Pharma Inc. (LTRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Leslie W. Kreis has been a net buyer of LTRN stock. They have purchased $186.0K and sold $0 worth of shares.
Leslie W. Kreis's most recent insider trade was on Jun 7, 2024, when they sold 8,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.48 |
| Discretionary |
| Dec 12, 2022 | INAB | $22.9K | Purchase | 9,214 | $2.48 | Discretionary |
| Dec 12, 2022 | INAB | $141.5K | Purchase | 57,052 | $2.48 | Discretionary |
| Jun 15, 2020 | LTRN | $0 | Conversion | 294,557 | $N/A | Discretionary |
| Jun 15, 2020 | LTRN | $0 | Conversion | 139,989 | $N/A | Discretionary |
| Jun 15, 2020 | LTRN | $0 | Conversion | 457,282 | $N/A | Discretionary |
| Jun 15, 2020 | LTRN | $0 | Conversion | 503,606 | $N/A | Discretionary |
| Jun 15, 2020 | LTRN | $0 | Conversion | 61,214 | $N/A | Discretionary |